Roche Expands Digital Pathology Platform with AI-Driven Algorithms
Roche’s navify digital pathology enterprise software now integrates a range of AI-driven algorithms, enabling enhanced cancer diagnostics.
Read MorePosted by Andy Lundin | Sep 17, 2024 | Digital Pathology |
Roche’s navify digital pathology enterprise software now integrates a range of AI-driven algorithms, enabling enhanced cancer diagnostics.
Read MorePosted by Andy Lundin | Sep 13, 2024 | Cardiovascular |
A new review finds that 20% of the global population carries a genetic risk for cardiovascular diseases due to high levels of lipoprotein(a).
Read MorePosted by Andy Lundin | Sep 11, 2024 | Digital Pathology, Lung Cancer |
The MET Predict assists in identifying NSCLC tumors with MET exon 14 skipping or MET amplification directly from H&E whole slide images.
Read MorePosted by Andy Lundin | Sep 9, 2024 | Diagnostic Technologies |
Researchers developed machine learning models to diagnose pediatric inflammatory conditions by analyzing cell-free RNA in blood plasma.
Read MorePosted by Andy Lundin | Sep 6, 2024 | Cancer |
Researchers developed a new nanomaterial-based technology that detects cancer mutant genes in blood with unparalleled sensitivity.
Read More